Cargando…
Sclerostin Inhibition in the Management of Osteoporosis
The recognition of the importance of the Wnt-signaling pathway in bone metabolism and studies of patients with rare skeletal disorders characterized by high bone mass identified sclerostin as target for the development of new therapeutics for osteoporosis. Findings in animals and humans with scleros...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824823/ https://www.ncbi.nlm.nih.gov/pubmed/27016922 http://dx.doi.org/10.1007/s00223-016-0126-6 |